Sugi Predict

Sugi Predict / Compounds / SCHEMBL29656785

SCHEMBL29656785

SCHEMBL29656785

Clc1ccc(N2CCCCC2)nc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 8/20 0.76
▸ CNR1 P21554 1/20 0.54
▸ CYP1A2 P05177 1/20 0.53
▸ MAPT P10636 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ ALOX12 P18054 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ UBE2T Q9NPD8 1/20 0.50
▸ ADK P55263 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ TMEM97 Q5BJF2 3/20 0.47
▸ SIGMAR1 Q99720 3/20 0.47
▸ HTR1A P08908 2/20 0.47
▸ DRD2 P14416 2/20 0.47
▸ DRD4 P21917 2/20 0.47
▸ HTR2A P28223 2/20 0.47
▸ HTR2C P28335 2/20 0.47
▸ HTR7 P34969 2/20 0.47
▸ DRD3 P35462 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16695272 0.98 CNR2 (0.73) CNR2CNR1CYP1A2MAPTALDH1A1
SCHEMBL22581782 0.83 CNR2 (0.56) CNR2CYP1A2ALDH1A1KMT2ASIGMAR1
SCHEMBL1447393 0.82 CNR2 (0.55) CNR2ALDH1A1KMT2ATMEM97SIGMAR1
SCHEMBL1998095 0.82 CNR2 (0.55) CNR2MAPTALDH1A1NPSR1KMT2A
SCHEMBL194226 0.81 HTR3A (0.57) CNR2CYP1A2ALDH1A1KMT2ASIGMAR1
SCHEMBL972745 0.81 CNR2 (0.54) CNR2ALDH1A1KMT2ATMEM97SIGMAR1
SCHEMBL3911609 0.81 CNR2 (0.64) CNR2CYP1A2MAPTALDH1A1LMNA
SCHEMBL6125262 0.81 KMT2A (0.58) CNR2KMT2ATMEM97SIGMAR1HTR1A
Hydrochloric Acid SCHEMBL21521416 0.79 HTR3A (0.55) CNR2CYP1A2ALDH1A1KMT2ASIGMAR1
SCHEMBL5235836 0.78 CNR2 (0.63) CNR2CNR1MAPTADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12037328-B2 Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 PRAMANA PHARMACEUTICALS INC. (CA) 2024-07-16 — — US disclosed
US-11358956-B2 Compounds containing polysubstituted benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 PRAMANA PHARMACEUTICALS INC. (CA) 2022-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11358956-B2 Compounds containing polysubstituted benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 GPR119, GPR27, GCGR CNR2 10/4885CNR1 27/4885CYP1A2 1143/4885
US-12037328-B2 Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 GPR119, GPR3, GPR39 CNR2 40/4885CNR1 69/4885CYP1A2 1150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.